Michael Richman

Michael Richman has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Acer Therapeutics Inc. and Genvec Inc. The record holds 7 filings, for trades running from 31 December 2015 to 16 June 2017.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 20 June 2017, the filings show an option exercise worth €7,670 in Genvec Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.